(Q35102313)

6 August 2017

1 reference

title

Mastitis therapy and pharmacology (English)

1 reference

6 August 2017

1 reference

Ronald J Erskine

1

1 reference

6 August 2017

Sarah Wagner

series ordinal

2

1 reference

6 August 2017

Fred J DeGraves

series ordinal

3

1 reference

6 August 2017

publication date

1 March 2003

1 reference

Veterinary Clinics of North America: Food Animal Practice

6 August 2017

published in

1 reference

6 August 2017

volume

19

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

109-38, vi

1 reference

Temporal patterns of lost milk production following clinical mastitis in a large Michigan Holstein herd

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Shedding pattern of Staphylococcus aureus from bovine intramammary infections

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Antibiotic treatment of mastitis: comparison of intramammary and intramammary plus intramuscular therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Anti-inflammatory ketoprofen in the treatment of field cases of bovine mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Naturally occurring acute coliform mastitis in Holstein cattle.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Bacteremia associated with naturally occuring acute coliform mastitis in dairy cows

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Determination of milk and mammary tissue concentrations of ceftiofur after intramammary and intramuscular therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Field trials with cefoperazone in the treatment of bovine clinical mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Comparison of seven antibiotic treatments with no treatment for bacteriological efficacy against bovine mastitis pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of intramammary antibiotic therapy for treatment of clinical mastitis caused by environmental pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Financial analysis of alternative treatments for clinical mastitis associated with environmental pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Comparison of treatment of mastitis by oxytocin or antibiotics following detection according to changes in milk electrical conductivity prior to visible signs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Comparison of success of antibiotic therapy during lactation and results of antimicrobial susceptibility tests for bovine mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Intramuscular treatment of subclinical staphylococcal mastitis in lactating cows with penicillin G, methicillin and their esters.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of intramuscular oxytetracycline as a dry cow treatment for Staphylococcus aureus mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Staphylococcus aureus Mastitis: Pathogenesis and Treatment with Bovine Interleukin-1β and Interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Recombinant bovine interleukin-2 and dry cow therapy: efficacy to cure and prevent intramammary infections, safety, and effect on gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Efficacy of recombinant bovine interleukin-2 as an adjunct to dry cow therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Sources of intramammary infections from Staphylococcus aureus in dairy heifers at first parturition

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Influence of prepartum antibiotic therapy on intramammary infections in primigravid heifers during early lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Effect of dexamethasone on experimental Escherichia coli mastitis in the cow

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Anti-inflammatory therapy in acute endotoxin-induced bovine mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Effect of steroidal anti-inflammatory drugs on Escherichia coli endotoxin-induced mastitis in the cow.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Regulation of L-selectin and CD18 on bovine neutrophils by glucocorticoids: effects of cortisol and dexamethasone

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Glucocorticoid receptor down-regulation in neutrophils of periparturient cows

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

The influence of anti-inflammatory therapy on bacterial clearance following intramammary Escherichia coli challenge in goats

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Hydroxyl-free radicals and anti-inflammatory drugs: biological inactivation studies and reaction rate constants

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Action of ketoprofen on hepatic lysosome in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Phmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

Comparison of fluid and flunixin meglumine therapy in combination and individually in the treatment of toxic mastitis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0720%2802%2900067-1

7 January 2021

10.1016/S0749-0720(02)00067-1

Identifiers

DOI

1 reference

6 August 2017

1 reference